| Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report Remap-Cap Investigators, AC Gordon, PR Mouncey, F Al-Beidh, ... Medrxiv, 2021.01. 07.21249390, 2021 | 1310 | 2021 |
| Genetic mechanisms of critical illness in COVID-19 E Pairo-Castineira, S Clohisey, L Klaric, AD Bretherick, K Rawlik, D Pasko, ... Nature 591 (7848), 92-98, 2021 | 1298 | 2021 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1017 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 815 | 2020 |
| Adjunctive glucocorticoid therapy in patients with septic shock B Venkatesh, S Finfer, J Cohen, D Rajbhandari, Y Arabi, R Bellomo, ... New England Journal of Medicine 378 (9), 797-808, 2018 | 771 | 2018 |
| High-frequency oscillation for acute respiratory distress syndrome D Young, SE Lamb, S Shah, I MacKenzie, W Tunnicliffe, R Lall, K Rowan, ... New England Journal of Medicine 368 (9), 806-813, 2013 | 768 | 2013 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 715 | 2021 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 599 | 2021 |
| Acute respiratory distress syndrome and acute lung injury A Dushianthan, MPW Grocott, AD Postle, R Cusack Postgraduate medical journal 87 (1031), 612-622, 2011 | 399 | 2011 |
| A randomised, controlled trial of the pulmonary artery catheter in critically ill patients A Rhodes, RJ Cusack, PJ Newman, MR Grounds, DE Bennett Intensive care medicine 28, 256-264, 2002 | 337 | 2002 |
| Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) v influenza A infection I Martin-Loeches, T Lisboa, A Rhodes, RP Moreno, E Silva, C Sprung, ... Intensive care medicine 37, 272-283, 2011 | 226 | 2011 |
| The strong ion gap does not have prognostic value in critically ill patients in a mixed medical/surgical adult ICU R Cusack, A Rhodes, P Lochhead, B Jordan, S Perry, J Ball, R Grounds, ... Intensive care medicine 28, 864-869, 2002 | 219 | 2002 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 189 | 2021 |
| Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic–the risk of aerosol generation during medical procedures KA Thompson, JV Pappachan, AM Bennett, H Mittal, S Macken, BK Dove, ... PloS one 8 (2), e56278, 2013 | 140 | 2013 |
| Effect of intravenous interferon β-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a … VM Ranieri, V Pettilä, MK Karvonen, J Jalkanen, P Nightingale, D Brealey, ... Jama 323 (8), 725-733, 2020 | 137 | 2020 |
| Preliminary studies for an immunotherapeutic approach to the treatment of human myeloma using chimeric anti-CD38 antibody FK Stevenson, AJ Bell, R Cusack, TJ Hamblin, CJ Slade, MB Spellerberg, ... | 119 | 1991 |
| Immunonutrition for acute respiratory distress syndrome (ARDS) in adults A Dushianthan, R Cusack, VA Burgess, MPW Grocott, PC Calder Cochrane Database of Systematic Reviews, 2019 | 117 | 2019 |
| Clinical review: Exogenous surfactant therapy for acute lung injury/acute respiratory distress syndrome-where do we go from here? A Dushianthan, R Cusack, V Goss, AD Postle, MPW Grocott Critical Care 16, 1-11, 2012 | 103 | 2012 |
| Effect of protocolized weaning with early extubation to noninvasive ventilation vs invasive weaning on time to liberation from mechanical ventilation among patients with … GD Perkins, D Mistry, S Gates, F Gao, C Snelson, N Hart, L Camporota, ... Jama 320 (18), 1881-1888, 2018 | 99 | 2018 |
| Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial YM Arabi, AC Gordon, LPG Derde, AD Nichol, S Murthy, FA Beidh, ... Intensive care medicine 47, 867-886, 2021 | 86 | 2021 |
Mike GrocottProfessor of Anaesthesia & Critical Care Medicine, University of Southampton / Duke UniversityVerified email at soton.ac.uk
